[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100196816":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":44,"collaborators":7,"id":46,"slug":7,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":47,"sex":53,"minAge":54,"maxAge":7,"enrollmentInfo":55,"targetDuration":7,"studyType":58,"phases":7,"briefSummary":59,"conditions":60,"keywords":66,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"University Hospital, Basel, Switzerland","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Christian Mueller, Prof. Dr. MD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+ 41 61328 65 49","Christian.Mueller@usb.ch",[18],{"facility":19,"status":20,"city":21,"state":7,"zip":22,"country":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"University Hospital Basel","RECRUITING","Basel","4031","Switzerland",{"type":25,"coordinates":26},"Point",[27,28],7.57327,47.55839,{"lat":28,"lon":27},[31,32,33,36,38,40,42],{"name":10,"role":14,"phone":7,"phoneExt":7,"email":7},{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"name":34,"role":35,"phone":7,"phoneExt":7,"email":7},"Tobias Reichlin, MD","SUB_INVESTIGATOR",{"name":37,"role":35,"phone":7,"phoneExt":7,"email":7},"Michael Freese, UP",{"name":39,"role":35,"phone":7,"phoneExt":7,"email":7},"Raphael Twerenbold, MD",{"name":41,"role":35,"phone":7,"phoneExt":7,"email":7},"Michael Zellweger, Prof.",{"name":43,"role":35,"phone":7,"phoneExt":7,"email":7},"Joan Walter, MD",{"type":45,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100196816",false,"NCT01838148","Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia","BASEL VIII Trial - Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia","BASEL VIII","Inclusion Criteria:\n\n* Patients presenting with suspected exercise-induced myocardial ischemia referred for rest\u002Fergometry myocardial perfusion SPECT\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years\n* Pregnancy\n* Unable or unwilling to give informed consent\n* Symptoms at rest or minor exertion","ALL","18 Years",{"count":56,"type":57},4000,"ESTIMATED","OBSERVATIONAL","The primary aim is to perform the largest study worldwide to evaluate novel biochemical and electrocardiographic signatures alone as well as in combination with the standard 12-lead exercise ECG in the detection of exercise-induced myocardial ischemia (diagnostic endpoint). The secondary aim is to evaluate these innovative tools in the risk prediction for the occurrence of cardiovascular death and acute myocardial infarction during long-term follow-up.",[61,62,63,64,65],"Coronary Artery Disease","Angina, Stable","Exercise Test","Biological Markers","SPECT",[67,68,69,70,65],"coronary artery disease","angina, stable","exercise test","biological Markers","2025-07-08",{"date":73,"type":74},"2025-07-11","ACTUAL",{"date":76,"type":7},"2004-05",{"date":78,"type":57},"2025-12",{"name":5,"class":6},1]